Healthcare · Drug Manufacturers General · NYSE
| Market cap | $297.14B |
|---|---|
| Trailing P/E | 18.7 |
| FCF yield | 5.0% |
| Revenue growth (YoY) | +9.6% |
| EPS growth (YoY) | +15.0% |
| FCF/share growth (YoY) | +14.9% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Novartis AG trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Lisa McClain | House | Buy | $1,001 - $15,000 | Nov 1, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| George Whitesides | House | Sell | $100,001 - $250,000 | Mar 24, 2025 |
| Daniel Goldman | House | Sell | $50,001 - $100,000 | Aug 4, 2023 |
| Daniel Goldman | House | Buy | $50,001 - $100,000 | Apr 3, 2023 |
| Donald Sternoff Honorable Beyer | House | Sell | $1,001 - $15,000 | Sep 19, 2021 |
| Alan S. Lowenthal | House | Sell | $1,001 - $15,000 | Nov 30, 2020 |
| Alan S. Lowenthal | House | Sell | $15,001 - $50,000 | Nov 30, 2020 |
| Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Nov 17, 2020 |
| Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Nov 5, 2020 |
| Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Aug 1, 2020 |
| Kevin Hern | House | Buy | $1,001 - $15,000 | Jul 28, 2020 |